Biocon puts cancer drug program on hold; TransCelerate hits milestone on trial initiative;

@FierceBiotech: Report: Seattle biotech VLST unloads assets and shuts doors. More | Follow @FierceBiotech

@JohnCFierce: Acceleron pitches $75M IPO as Celgene pushes partnership through PhII. News | Follow @JohnCFierce

@RyanMFierce: Now that "microbiome" means something to people... NuMe Health changes name to MicroBiome Therapeutics. Release | Follow @RyanMFierce

@EmilyMFierce: The Smithsonian plans to create a huge bank of genetic samples to enable large-scale genome sequencing. More | Follow @EmilyMFierce

> India's Biocon says that it has put a preclinical cancer program on hold after running into some patent issues. Story

> TransCelerate BioPharma reached its primary milestone in its Clinical Trial Comparator Network Initiative. Release

> Cyprotex, a U.K. drug testing company, says it is ready to expand after raising close to $11 million. Story

Medical Device News

@FierceMedDev: Navidea's losses widen as it waits for Lymphoseek to catch on. Article | Follow @FierceMedDev

@DamianFierce: Israel's Given Imaging had a record Q2 and believes better things are on the horizon. Report | Follow @DamianFierce

> Gene By Gene grabs GE-backed diagnostics startup. More

> Roche Dx cuts more diabetes jobs amid faltering sales. Report

> Medtronic implant could point to future of Parkinson's treatment. Story

Pharma News

@FiercePharma: Looking for a sales job? Lundbeck to hire > 200 to market antidepressant Brintellix, in prep for FDA nod. More | Follow @FiercePharma

@CarlyHFierce: In Vivus earnings, not a lot of revenue, but analysts seem optimistic about Zook's plans for Qsymia. Release | Follow @CarlyHFierce

> Novartis' ambitions for Afinitor suffer on liver-cancer failure. More

> Valeant CEO: Merger of equals still on the table. Story

> China revokes patent on Gilead's Viread. Article

Biomarkers News

> Biomarker IDs cancer patients most likely to respond to EGFR inhibitors. Item

> NIH pushes for biomarker research to catch up with needs of kids. Story

> Are cancer biomarker tests grossly underused? More

> Elevated carbon monoxide levels in breath can point to infection. Story

> Broad, Dana-Farber license lung cancer biomarker IP to MolecularMD. Article

> Altered enzyme indicates Alzheimer's-like dementia. Item

Drug Delivery News

@MichaelGFierce: 'Soft robotic' hydrogel arms show drug delivering capability. More | Follow @MichaelGFierce

> UCSD surgeons deliver cancer drugs to brain with ClearPoint MRI tech. Story

> 3M sells dry powder inhaler rights to Adamis. News

> Next-gen Alzheimer's drug targets brain enzyme. Story

> Ocular Therapeutix nets FDA panel meeting for eye surgery hydrogel. Item

> Halozyme regrouping after ViroPharma trial flop. Article

And Finally... In an effort to advance drug and disease research in children, a unit of the National Institutes of Health aims to fund studies of biomarkers of adult ailments for use in pediatric patients. Story